Positive trial results offer hope for those with ultra-rare epileptic disorder
Category: News
New data show strong efficacy of CD388 in phase 2b trial
Introduction This year’s NHS ConfedExpo took place on 11–12 June at Manchester Central, bringing together around 9000 attendees. […]
PMGroup Worldwide and Visions4Health have launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise collaborations that deliver […]
Enter this year’s famous competition
The pilot will see GP practices look at patient records to identify those most at risk
Signadori is advancing a platform designed to overcome the challenges of treating solid cancers
The candidate is being evaluated as both a monotherapy and in combination pembrolizumab
Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US
Collaboration aims to improve rapid detection and personalised treatments